Company: XOMAP
Filing Date: 2025-09-03
Form Type: SC TO-T/A
Source: 0001193125-25-195061
Chunk: 1

Company: XOMA Royalty Corp
Filing Date: 2025-09-03
Form: SC TO-T/A
Chunk 1
---
 to purchase all of the issued and outstanding common shares, with a nominal value of €0.12 per share (“ Shares”), in the capital of LAVA Therapeutics N.V., a public limited liability company ( naamloze vennootschap) organized under the laws of the Netherlands, having its corporate seat ( statutaire zetel) in Utrecht, the Netherlands, registered with the Dutch trade register under number 65335740 (“ LAVA”), for a price per Share of (i) $1.16 (the “ Base Price Per Share”), (ii) an additional amount of cash of up to $0.08 per Share (such amount as finally determined pursuant to the Purchase Agreement (as defined below), the “ Additional Price Per Share” and together with the Base Price Per Share, the “ Cash Amount”), payable subject to any applicable tax withholding and without interest, and (iii) one non-transferablecontractual contingent value right (“ CVR”) for each Share, which shall represent the right to receive potential payments, in cash, described in, and subject to and in accordance with the terms and conditions of, the CVR Agreement (as described below), subject to any applicable tax withholding and without interest (such amount, the “ CVR Amount,” and together with the Cash Amount, the “ Offer Consideration”), all upon the terms and subject to the conditions described in the Offer to Purchase, dated August 14, 2025 (together with any subsequent amendments or supplements thereto, the “ Offer to Purchase”) and in the related Letter of Transmittal, copies of which are attached hereto as exhibits (a)(1)(A) and (a)(1)(B), respectively. Accordingly, the total Cash Amount that Purchaser may pay pursuant to the terms of the Offer and Purchase Agreement is between $1.16 and $1.24 per Share. The Offer is being made pursuant to the Share Purchase Agreement, dated as of August 3, 2025 (together with any amendments or supplements thereto, the “ Purchase Agreement”), among LAVA and Purchaser, a copy of which is filed as Exhibit (d)(1) hereto and incorporated herein by reference with respect to Items 4 through 11 of this Schedule TO. Except as otherwise set forth in this Amendment, the information set forth in the Schedule TO remains unchanged and is incorporated herein by reference to the extent relevant to the items in this Amendment. Capitalized terms used but not defined herein have the meanings ascribed